» Articles » PMID: 35328702

Insights in Post-Translational Modifications: Ubiquitin and SUMO

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35328702
Authors
Affiliations
Soon will be listed here.
Abstract

Both ubiquitination and SUMOylation are dynamic post-translational modifications that regulate thousands of target proteins to control virtually every cellular process. Unfortunately, the detailed mechanisms of how all these cellular processes are regulated by both modifications remain unclear. Target proteins can be modified by one or several moieties, giving rise to polymers of different morphology. The conjugation cascades of both modifications comprise a few activating and conjugating enzymes but close to thousands of ligating enzymes (E3s) in the case of ubiquitination. As a result, these E3s give substrate specificity and can form polymers on a target protein. Polymers can be quickly modified forming branches or cleaving chains leading the target protein to its cellular fate. The recent development of mass spectrometry(MS) -based approaches has increased the understanding of ubiquitination and SUMOylation by finding essential modified targets in particular signaling pathways. Here, we perform a concise overview comprising from the basic mechanisms of both ubiquitination and SUMOylation to recent MS-based approaches aimed to find specific targets for particular E3 enzymes.

Citing Articles

Advances in the Development of Mitochondrial Pyruvate Carrier Inhibitors for Therapeutic Applications.

Politte H, Maram L, Elgendy B Biomolecules. 2025; 15(2).

PMID: 40001526 PMC: 11852594. DOI: 10.3390/biom15020223.


Redox regulation of TRIM28 facilitates neuronal ferroptosis by promoting SUMOylation and inhibiting OPTN-selective autophagic degradation of ACSL4.

Liu W, Zhu Y, Ye W, Xiong J, Wang H, Gao Y Cell Death Differ. 2025; .

PMID: 39875520 DOI: 10.1038/s41418-025-01452-4.


Post-translational modifications and bronchopulmonary dysplasia.

Yang K, He T, Sun X, Dong W Front Pediatr. 2025; 12():1426030.

PMID: 39830627 PMC: 11738936. DOI: 10.3389/fped.2024.1426030.


Neddylation steers the fate of cellular receptors.

Park J, Lee M, Lee J, Moon G, Kim S, Chun Y Exp Mol Med. 2024; 56(12):2569-2577.

PMID: 39623094 PMC: 11671587. DOI: 10.1038/s12276-024-01358-0.


Mechanistic exploration of ubiquitination-mediated pathways in cerebral ischemic injury.

Khanra S, Singh S, Singh T Mol Biol Rep. 2024; 52(1):22.

PMID: 39607439 DOI: 10.1007/s11033-024-10123-5.


References
1.
Kahyo T, Nishida T, Yasuda H . Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell. 2001; 8(3):713-8. DOI: 10.1016/s1097-2765(01)00349-5. View

2.
Dawlaty M, Malureanu L, Jeganathan K, Kao E, Sustmann C, Tahk S . Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell. 2008; 133(1):103-15. PMC: 2693193. DOI: 10.1016/j.cell.2008.01.045. View

3.
Hedglin M, Aitha M, Pedley A, Benkovic S . Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen. J Biol Chem. 2019; 294(13):5157-5168. PMC: 6442069. DOI: 10.1074/jbc.RA118.005297. View

4.
Vertegaal A . SUMO chains: polymeric signals. Biochem Soc Trans. 2010; 38(Pt 1):46-9. DOI: 10.1042/BST0380046. View

5.
Chiu Y, Sun Q, Chen Z . E1-L2 activates both ubiquitin and FAT10. Mol Cell. 2007; 27(6):1014-23. DOI: 10.1016/j.molcel.2007.08.020. View